Skip to main content

Table 2 Values of the carotid intima media thickness (IMT) of the patients < 40 years and ≥ 40 years

From: Risk factors for subclinical atherosclerosis in HIV-infected patients under and over 40 years: a case–control study

Variables < 40 y group ≥ 40 y group
Carotid MIT Median (P25; P75) p-value Carotid MIT Median (P25; P75) p-value
HAART use   p = 0.069   p = 0.166
Yes 0.735 (0.691; 0.792)   0.840 (0.772; 0.917)  
No 0,722 (0.677; 0.780)   0.827 (0.740; 0.915)  
CD4 T-lymphocytes (cells/mm3)   p = 0.373   p = 0.011
<200 0.720 (0.685; 0.782)   0.797 (0.742; 0.964)  
200 to 350 0.728 (0.681; 0.792)   0.822 (0.760; 0.919)  
≥ 350 0.731 (0.693; 0.779)   0.852 (0.802; 0.920)  
Viral load (copies/mL)   p = 0.269   p = 0.616
< 50 0.745 (0.677; 0.822)   0.836 (0.765; 0.135)  
50 to < 10.000 0.742 (0.705; 0.795)   0.837 (0.757; 0.940)  
10.000 to < 100.000 0.723 (0.681; 0.769)   0.852 (0.763; 0.922)  
≥ 100,000 0.690 (0.682; 0.741)   0.831 (0.775; 0.918)  
Types HAART regimens   p = 0.109   p = 0.132
No HAART use 0.722 (0.677; 0.780)   0.827 (0.740; 0.915)  
PI 0.733 (0.690; 0.767)   0.782 (0.732; 0.875)  
NNRTI 0.729 (0.696; 0.784)   0.837 (0.778; 0.897)  
Duration of use of HAART   p = 0,015   p = 0.070
No use 0.722 (0.677; 0.780)   0.827 (0.740; 0.915)  
< 5 years 0.730 (0.690; 0.790)   0.830 (0.757; 0.918)  
≥5 years 0.757 (0.730; 0.815)   0.864 (0.805; 0.915)